USPTO Examiner KOLOSOWSKI GAGER KATHERINE - Art Unit 3687

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18643179SESSION IDENTIFICATION METRICS THROUGH BLOOM FILTERSApril 2024May 2025Allow1210YesNo
18587361METHODS, SYSTEMS, AND MEDIA FOR ENHANCING A BLIND URL ESCROW WITH REAL TIME BIDDING EXCHANGESFebruary 2024February 2025Allow1210NoNo
18214719PUBLISHER TOOL FOR CONTROLLING SPONSORED CONTENT QUALITY ACROSS MEDIATION PLATFORMSJune 2023October 2024Allow1610YesNo
18249234DEVELOPMENT OF A PERSONALISED PERIODONTITIS SCORE FOR PATIENT RISK STRATIFICATION AND TARGETED THERAPYApril 2023September 2025Abandon3010NoNo
18134907Systems and Methods for Medical Instrument ManagementApril 2023May 2025Abandon2510NoNo
18134135METHOD OF MEDIATING PURCHASE OF PET MEDICATION AND SERVER THEREFORApril 2023May 2025Abandon2510NoNo
18029948MACHINE-LEARNING MODEL FOR GENERATING HEMOPHILIA PERTINENT PREDICTIONS USING SENSOR DATAApril 2023August 2025Allow2820YesNo
18029347INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUMMarch 2023April 2025Abandon2510NoNo
18118962INFORMATION PROCESSING APPARATUS AND INFORMATION PROCESSING METHODMarch 2023March 2025Abandon2410NoNo
18180325SYSTEMS AND METHODS FOR DYNAMICALLY DETERMINING EVENT CONTENT ITEMSMarch 2023July 2025Allow2921NoNo
17983293METHOD FOR PROCESSING MEDICAL IMAGESNovember 2022November 2025Abandon3620NoNo
17932279CLOUD LIFE MONITORING SYSTEMSeptember 2022November 2024Abandon2710NoNo
17881056SYSTEMS AND METHODS FOR FACILITATING MANAGING OF MEDICAL RECORDSAugust 2022August 2025Abandon3720NoNo
17870131CHOOSING DESIRED PRICE FOR PRODUCT ON PROMOTIONAL WEB PAGEJuly 2022March 2025Abandon3210NoNo
17838208Electronic Goal AttainmentJune 2022October 2025Abandon4010NoNo
17779598DISEASE PREDICTION DEVICE, PREDICTION MODEL GENERATION DEVICE, AND DISEASE PREDICTION PROGRAMMay 2022April 2025Abandon3410NoNo
17752480DISTRIBUTED INCENTIVE MANAGEMENTMay 2022December 2024Abandon3110NoNo
17664228APPARATUSES AND METHODS FOR MODELLING AND CONTROL OF ICE FORMATION DURING CRYOABLATION TREATMENTSMay 2022July 2024Allow2610NoNo
17742492PERSONAL BIOMETRIC ASSESSMENT SYSTEMMay 2022October 2025Abandon4120YesNo
17776042IMAGE ACQUISITION VISUALS FOR AUGMENTED REALITYMay 2022November 2024Abandon3110NoNo
17736145Correlating Health Conditions with Behaviors for Treatment Programs in Neurohumoral Behavioral TherapyMay 2022March 2025Allow3520YesNo
17582882SYSTEM AND METHOD FOR USING DEVICE DISCOVERY TO PROVIDE ADVERTISING SERVICESJanuary 2022July 2025Allow4121NoNo
17579243SYSTEM AND METHOD OF DEPLOYING NEURAL NETWORK BASED DIGITAL ADVERTISINGJanuary 2022April 2025Abandon3940NoNo
17573809PREDICTING TEMPORAL IMPACT OF INTERVENTIONS BY DECONVOLVING HISTORICAL RESPONSE DATAJanuary 2022March 2025Abandon3820YesNo
17573770MOBILE RADIOGRAPHY SYSTEM, RECORDING MEDIUM, AND RADIOGRAPHY SCHEDULE GENERATION METHODJanuary 2022November 2025Abandon4630NoNo
17571444Method Of Implementing a Decentralized User-Extensible System for Storing and Managing Unified Medical FilesJanuary 2022January 2026Abandon4830YesNo
17624677APPARATUS FOR DETERMINING INDICATION OF PAINJanuary 2022December 2024Abandon3610NoNo
17646494INTERACTIVE VOICE CAPABILITIES FOR PROSPECT DIGITAL ACQUISITIONDecember 2021November 2024Allow3431YesNo
17646113METHOD OF MANAGING DIGITAL CONTENT, DEVICE, AND READABLE STORAGE MEDIUMDecember 2021October 2024Abandon3420NoNo
17547637BUNDLE CLICKING SIMULATION TO VALIDATE A/B TESTING BANDIT STRATEGIESDecember 2021April 2025Abandon4021YesYes
17611410OPERATION PROFILE SYSTEMS AND METHODS FOR A COMPUTER-ASSISTED SURGICAL SYSTEMNovember 2021January 2025Allow3820YesNo
17515904PART REPLACEMENT REGISTRATION TOOLNovember 2021July 2025Abandon4440NoNo
17450339TEXT PROCESSING METHOD AND APPARATUSOctober 2021September 2025Abandon4740YesNo
17449329METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR AUTOMATICALLY SELECTING A NETWORK SOURCE FOR RETRIEVING CLINICAL INFORMATIONSeptember 2021July 2025Abandon4520NoNo
17448507MACHINE LEARNING SYSTEMS AND METHODS TO DIAGNOSE RARE DISEASESSeptember 2021July 2024Allow3420YesNo
17474681DYNAMIC GEOFENCING-ENABLED PHYSIOLOGICAL RISK MONITORING SYSTEM IN PHYSICAL AND MIXED REALITY ENVIRONMENTSSeptember 2021December 2024Allow3930YesNo
17401066WEB APPLICATION FOR SERVICE RECOMMENDATIONS WITH MACHINE LEARNINGAugust 2021December 2024Allow4010NoNo
17310176BAYESIAN CAUSAL INFERENCE MODELS FOR HEALTHCARE TREATMENT USING REAL WORLD PATIENT DATAJuly 2021June 2025Allow4740NoYes
17360557TRANSACTIONS USING A MOBILE DEVICE AND A CONTACTLESS CARDJune 2021May 2025Allow4770YesNo
17359620System for Optimizing Behavioral Changes of a User to Improve the User's WellbeingJune 2021December 2024Abandon4220NoNo
17238782Systems and Methods for Managing Incentive Campaigns and Automatically Approving Requests for IncentivesApril 2021July 2025Abandon5160NoYes
17283513SYSTEM AND METHOD FOR RECOMMENDING ITEMS IN CONVERSATIONAL STREAMSApril 2021February 2025Abandon4620NoNo
17159937SCALABLE METHOD AND SYSTEM FOR BUILDING INTERACTIVE LOGICJanuary 2021October 2023Abandon3330NoNo
17075541PREDICTING THE EFFECTIVENESS OF A MARKETING CAMPAIGN PRIOR TO DEPLOYMENTOctober 2020August 2025Allow5820NoYes
12570246ADVERTISEMENTS WITHIN TELEVISION ADVERTISEMENTSSeptember 2009April 2019Allow6090YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KOLOSOWSKI-GAGER, KATHERINE.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
1
(50.0%)
Examiner Reversed
1
(50.0%)
Reversal Percentile
77.8%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
4
Allowed After Appeal Filing
1
(25.0%)
Not Allowed After Appeal Filing
3
(75.0%)
Filing Benefit Percentile
36.1%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner KOLOSOWSKI-GAGER, KATHERINE - Prosecution Strategy Guide

Executive Summary

Examiner KOLOSOWSKI-GAGER, KATHERINE works in Art Unit 3687 and has examined 18 patent applications in our dataset. With an allowance rate of 50.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 44 months.

Allowance Patterns

Examiner KOLOSOWSKI-GAGER, KATHERINE's allowance rate of 50.0% places them in the 12% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by KOLOSOWSKI-GAGER, KATHERINE receive 3.33 office actions before reaching final disposition. This places the examiner in the 92% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by KOLOSOWSKI-GAGER, KATHERINE is 44 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +45.0% benefit to allowance rate for applications examined by KOLOSOWSKI-GAGER, KATHERINE. This interview benefit is in the 90% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 18.8% of applications are subsequently allowed. This success rate is in the 18% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 6.7% of cases where such amendments are filed. This entry rate is in the 7% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 20% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.